Neovascular AMD Can Cause Rapid and Severe Vision Loss. Qdata® Can Help Advance Treatments for These Patients.

Qdata nAMD (neovascular age-related macular degeneration) is an exclusive dataset of 1M+ patients with a detailed view of the patient journey, disease progression and anti-VEGF treatments.

About Qdata

Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes. Qdata spans ophthalmology, neurology, and urology to help unlock quality insights across the entire drug and device development cycle.

animated magnifying glass icon

Exclusive nAMD Insights

Only found here from the IRIS Registry (Intelligent Research in Sight)


Detailed Understanding of Disease Progression

Key variables including visual acuity and CST

animated person atop arrow icon

Timely View of Anti-VEGF Treatments

Track usage and outcomes

Qdatan_nAMD (1)

By the Numbers


Total de-identified patients with nAMD*


Total de-identified nAMD patients with anti-VEGF injections

+ Years

Average length of follow-up for nAMD patients

eye looking into equipment with a band of light

*Defined as patients >=50 with >=1 ICD-10 code for nAMD (codes H35.32*) from January 2016 to September 2023, with a corresponding CPT or HCPCS code on the same date as the diagnosis.

Meet with a Qdata Expert or Request a Data Count

Key Variables in Qdata nAMD

Curated variables are extracted from EHR data to be utilized based on your research needs.

Visual Acuity

Central Subfield Thickness (CST)

Unstructured Data Enables Deeper Understanding

Qdata modules consist of carefully curated datasets that are readily available for research purposes, enabling the generation of real-world evidence (RWE).


Verana Health applies clinician-informed algorithms to unstructured EHR data at scale to help extract key information on visual acuity, CST, anti-VEGF procedure details and more, which can then be analyzed across large populations in a reliable manner.


This can give life sciences companies unprecedented insights to better understand treatment patterns and outcomes, run comparative effectiveness studies, monitor market uptake, and more.


of Medical Data Remains Unstructured


Learn About Qdata Anti-VEGF Market Tracker

Qdata Anti-VEGF Market Tracker tracks real-world usage that is refreshed monthly


Talk to a Qdata Expert

Take a minute to submit your contact information and one of our team members will reach out to you.